Division of Urology, Albany Medical Center, Albany, NY.
Duke University School of Medicine, Durham, NC.
Urology. 2022 Sep;167:218-223. doi: 10.1016/j.urology.2022.05.009. Epub 2022 May 25.
To investigate the impact of extirpative surgery for pubic bone osteomyelitis with pubovesical fistula on prostate cancer survivors' physical and mental health.
The Short Form 12 (SF-12) is a validated instrument for assessing health-related quality of life (HRQOL). We reviewed a prospectively maintained database of patients treated with extirpative surgery for pubovesical fistula from 2017-2021 who completed the SF-12. Wilcoxon signed-rank and McNemar's tests were used to analyze changes in SF-12 following surgery. Narcotic prescriptions in the year before and after surgery were assessed as an additional measure of pain burden.
Eighteen patients were included. Four had pre-operative SF-12s, 3 had post-operative SF-12s, and 11 had both. Median age was 76.5 years (IQR 71.75-80.00). All patients had previous radiation for prostate cancer. Compared to global pre-operative scores, post-operative physical composite scores (PCS) significantly increased (29.95 ± 8.59 vs 42.48 ± 7.18; P <.001), but mental composite scores (MCS) were similar (45.35 ± 9.98 vs 52.21 ± 8.23). When comparing individual, paired pre-operative and post-operative scores there was a significant improvement in PCS (30.56 ± 9.87 vs 45.45 ± 8.56; P = .005), but not MCS (47.49 ± 6.92 vs 51.60 ± 8.88). Median morphine milligram equivalent significantly decreased in the year post-surgery compared to the year prior (103.1, 33.0-250.9 vs 34.25, 0.0-105.9; P = .0008).
For prostate cancer survivors with pubovesical fistula and pubic bone osteomyelitis, urinary diversion with pubic bone resection improves physical functioning and decreases narcotic prescriptions without untoward effects on mental health.
探讨耻骨骨炎合并膀胱尿道瘘患者行耻骨切除术对前列腺癌幸存者身心健康的影响。
健康相关生活质量(HRQOL)的评估采用 SF-12 量表。我们回顾性分析了 2017 年至 2021 年期间接受耻骨骨切开术治疗膀胱尿道瘘的患者的前瞻性数据库,这些患者完成了 SF-12 量表。采用 Wilcoxon 符号秩检验和 McNemar 检验分析手术前后 SF-12 量表的变化。通过评估术后一年前后的阿片类药物处方,作为疼痛负担的额外衡量标准。
共纳入 18 例患者。术前 SF-12 量表 4 例,术后 SF-12 量表 3 例,两者均有 11 例。中位年龄为 76.5 岁(IQR 71.75-80.00)。所有患者均有前列腺癌放疗史。与全球术前评分相比,术后生理综合评分(PCS)显著升高(29.95±8.59 与 42.48±7.18;P<.001),但心理综合评分(MCS)相似(45.35±9.98 与 52.21±8.23)。比较个体术前和术后配对评分,PCS 显著改善(30.56±9.87 与 45.45±8.56;P=.005),而 MCS 无显著变化(47.49±6.92 与 51.60±8.88)。与术前相比,术后一年吗啡等效毫克数中位数显著减少(103.1,33.0-250.9 与 34.25,0.0-105.9;P=.0008)。
对于耻骨骨炎合并膀胱尿道瘘和耻骨骨骨髓炎的前列腺癌幸存者,耻骨切除的尿流改道可改善生理功能并减少阿片类药物处方,而不会对心理健康产生不良影响。